Tag:
pharmacovigilance
Latest Headlines
Latest Headlines
Stanford algorithm uncovers drug side effects
When doctors believe a drug's side effects are behind a patient's aches and pains, they can report their suspicion to the FDA. But it can be hard to know whether those adverse events are really drug-related or the result of another illness. Now Stanford researchers have developed a computer algorithm to show which adverse events are likely to be drug-related, shining a light on new bad reactions to meds as well.
Startups ease access to online data on medical product side effects
The FDA has digested huge amounts of data on the hazardous effects of medical products for decades, and some entrepreneurs have set out to turn a profit from the information. Two recently launched...
FierceBiotech IT will be back in action Jan. 3, or sooner...
The team at FierceBiotech IT will be taking a break between Christmas and New Year's Day, but we'll be back after then to cover more top news on bioinformatics, clinical trials software, patient
EMA boosts war on bad drug reactions in €222.5M budget
The European Medicines Agency (EMA) plans to scale up its battle against harmful drug reactions in 2012 after citing figures that the problem costs thousands of lives and €79 billion a year. The
U.K. mulls drug-reaction reports on Twitter, Facebook
As healthcare agencies aim to boost reporting of adverse drug reactions, the U.K.'s MHRA is considering whether to allow docs to use smartphone apps, Twitter and Facebook to report such events,...
Supercomputers combat bad drug events for Boston hospital
A new front is opening up in the ongoing effort to identify bad drug reactions, a major sore spot for drug companies and healthcare providers. Harvard doctors are using supercomputing technology to
Regulator initiates EU-wide safety monitoring
If you're selling drugs in Europe, you're now less than a year away from having to submit drug data in the newly released formats developed by the European Medicines Agency. Use of the forms will be
1,300 new hires planned for FDA expansion
The FDA is hiring some 1,300 badly-needed workers  to help with drug
Millennium spent $1.3M on lobbying
According to public records, Millennium Pharmaceuticals spent $1.3 million in 2007 lobbying the federal government on patent reform and biotech drug regulation. A bill--currently in the Senate--had
In speech, Lilly CEO calls for drug monitoring
In a speech at the Cleveland Clinic, Eli Lilly chairman and CEO Sidney Taurel ( photo ) called for greater use of health IT in order to
